Furthermore, BIRC6 overexpression has been associated with worse overall survival and shorter disease-free survival in colorectal cancer [ 11], prostate cancer [ 32, 35], and childhood AML and acute lymphoblastic leukemia (ALL) [ 31, 36]. Here, BIRC6 is linked to acute myeloid leukemia.